Changes in bone marrow FDG uptake in multiple myeloma patients before and after treatment.

Conclusion: A novel methodology was used to quantify bone marrow activity portrayed by FDG-PET/CT for the whole skeleton of MM patients. The significant decrease in GSUVmean and GSUVmax uptake from pre- to post-treatment in the HDT group shows that the high dose treatment was likely successful to significantly decrease the cancer cells in the bone marrow of those patients.

Source: Journal of Nuclear Medicine - May 23, 2018 Category: Nuclear Medicine Authors: Zirakchian Zadeh, M., Raynor, W., Oestergaard, B., Taghvaei, R., Acosta-Montenegro, O., Mehdizadeh Seraj, S., Saboury, B., Yellanki, D., Al-zaghal, A., Ayubcha, C., Werner, T., Abildgaard, N., Zhuang, H., Hoilund-Carlsen, P. F., Alavi, A. Tags: Leukemia/Lymphoma/Myeloma Poster Session Source Type: research